Literature DB >> 35435909

Real-Time Detection and Capture of Invasive Cell Subpopulations from Co-Cultures.

Ghada M Sharif1, Leon Der2, Anna T Riegel1, Makarand Paranjape2, Anton Wellstein3.   

Abstract

Invasion and metastatic spread of cancer cells are the major cause of death from cancer. Assays developed early on to measure the invasive potential of cancer cell populations typically generate a single endpoint measurement that does not distinguish between cancer cell subpopulations with different invasive potential. Also, the tumor microenvironment consists of different resident stromal and immune cells that alter and participate in the invasive behavior of cancer cells. Invasion into tissues also plays a role in immune cell subpopulations fending off microorganisms or eliminating diseased cells from the parenchyma and endothelial cells during tissue remodeling and angiogenesis. Real-Time Cellular Analysis (RTCA) that utilizes impedance biosensors to monitor cell invasion was a major step forward beyond endpoint measurement of invasion: this provides continuous measurements over time and thus can reveal differences in invasion rates that are lost in the endpoint assay. Using current RTCA technology, we expanded dual-chamber arrays by adding a further chamber that can contain stromal and/or immune cells and allows measuring the rate of invasion under the influence of secreted factors from co-cultured stromal or immune cells over time. Beyond this, the unique design allows for detaching chambers at any time and isolating of the most invasive cancer cell, or other cell subpopulations that are present in heterogeneous mixes of tumor isolates tested. These most invasive cancer cells and other cell subpopulations drive malignant progression to metastatic disease, and their molecular characteristics are important for in-depth mechanistic studies, the development of diagnostic probes for their detection, and the assessment of vulnerabilities. Thus, the inclusion of small- or large-molecule drugs can be used to test the potential of therapies that target cancer and/or stromal cell subpopulations with the goal of inhibiting (e.g., cancer cells) or enhancing (e.g., immune cells) invasive behavior.

Entities:  

Mesh:

Year:  2022        PMID: 35435909      PMCID: PMC9135070          DOI: 10.3791/63512

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.424


  14 in total

1.  MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ.

Authors:  F R Miller; S J Santner; L Tait; P J Dawson
Journal:  J Natl Cancer Inst       Date:  2000-07-19       Impact factor: 13.506

Review 2.  A review of impedance measurements of whole cells.

Authors:  Youchun Xu; Xinwu Xie; Yong Duan; Lei Wang; Zhen Cheng; Jing Cheng
Journal:  Biosens Bioelectron       Date:  2015-10-22       Impact factor: 10.618

3.  Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes.

Authors:  Yoko S DeRose; Guoying Wang; Yi-Chun Lin; Philip S Bernard; Saundra S Buys; Mark T W Ebbert; Rachel Factor; Cindy Matsen; Brett A Milash; Edward Nelson; Leigh Neumayer; R Lor Randall; Inge J Stijleman; Bryan E Welm; Alana L Welm
Journal:  Nat Med       Date:  2011-10-23       Impact factor: 53.440

4.  Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor.

Authors:  D C Stylianou; A Auf der Maur; D P Kodack; R T Henke; S Hohn; J A Toretsky; A T Riegel; A Wellstein
Journal:  Oncogene       Date:  2009-07-27       Impact factor: 9.867

Review 5.  Collective cell migration in morphogenesis, regeneration and cancer.

Authors:  Peter Friedl; Darren Gilmour
Journal:  Nat Rev Mol Cell Biol       Date:  2009-07       Impact factor: 94.444

6.  Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization.

Authors:  R Cailleau; M Olivé; Q V Cruciger
Journal:  In Vitro       Date:  1978-11

7.  Mechanistic modeling of the effects of myoferlin on tumor cell invasion.

Authors:  Marisa C Eisenberg; Yangjin Kim; Ruth Li; William E Ackerman; Douglas A Kniss; Avner Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-30       Impact factor: 11.205

8.  The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.

Authors:  S BOYDEN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

9.  An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer.

Authors:  Ghada M Sharif; Moray J Campbell; Apsra Nasir; Surojeet Sengupta; Garrett T Graham; Max H Kushner; William B Kietzman; Marcel O Schmidt; Gray W Pearson; Olivier Loudig; Susan Fineberg; Anton Wellstein; Anna T Riegel
Journal:  Cancer Res       Date:  2021-06-16       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.